Forschung Kinderdermatologie

Schwerpunkte der Arbeitsgruppe Kinderdermatologie:

Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids. Jensen JM, Ahrens K, Meingassner J, Scherer A, Bräutigam M, Stütz A, Schwarz T, Fölster-Holst R, Harder J, Gläser R, Proksch E. Exp Dermatol. 2011 Jun 24.

Treatment of acute radiodermatitis with an oil-in-water emulsion following radiation therapy for breast cancer: a controlled, randomized trial. Jensen JM, Gau T, Schultze J, Lemmnitz G, Fölster-Holst R, May T, Abels C, Proksch E. Strahlenther Onkol. 2011 Jun;187(6):378-84. Epub 2011 May 16.

A comprehensive analysis of the COL29A1 gene does not support a role in eczema. Naumann A, Söderhäll C, Fölster-Holst R, Baurecht H, Harde V, Müller-Wehling K, Rodríguez E, Ruether A, Franke A, Wagenpfeil S, Novak N, Mempel M, Kalali BN, Allgaeuer M, Koch J, Gerhard M, Melén E, Wahlgren CF, Kull I, Stahl C, Pershagen G, Lauener R, Riedler J, Doekes G, Scheynius A, Illig T, von Mutius E, Schreiber S, Kere J, Kabesch M, Weidinger S. J Allergy Clin Immunol. 2011 May;127(5):1187-94.e7.

Juvenile psoriasis: rewarding endeavours in contemporary dermatology and pediatrics. Radtke MA, Fölster-Holst R, Beikert F, Herberger K, Augustin M. G Ital Dermatol Venereol. 2011 Feb;146(1):31-45. Review.

Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitis. Novak N, Thaci D, Hoffmann M, Fölster-Holst R, Biedermann T, Homey B, Schaekel K, Stefan JA, Werfel T, Bieber T, Sager A, Zuberbier T. Int Arch Allergy Immunol. 2011;155(3):252-6.

Permethrin treatment of head lice with knockdown resistance-like gene. Bialek R, Zelck UE, Fölster-Holst R. N Engl J Med. 2011 Jan 27;364(4):386-7.

Prevention of follicular penetration: barrier-enhancing formulations against the penetration of pollen allergens into hair follicles. Meinke MC, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A, Bohnsack K, Rippke F, Galecka J, Fölster-Holst R, Lademann J. Skin Pharmacol Physiol. 2011;24(3):144-50.

Dermal fibroblasts from acute inflamed atopic dermatitis lesions display increased eotaxin/CCL11 responsiveness to interleukin-4 stimulation. Gahr N, Fölster-Holst R, Weichenthal M, Christophers E, Schröder JM, Bartels J. Br J Dermatol. 2011 Mar;164(3):586-92.

Probiotics in the treatment and prevention of atopic dermatitis. Fölster-Holst R. Ann Nutr Metab. 2010;57 Suppl:16-9.

Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Oji V, Eckl KM, Aufenvenne K, Nätebus M, Tarinski T, Ackermann K, Seller N, Metze D, Nürnberg G, Fölster-Holst R, Schäfer-Korting M, Hausser I, Traupe H, Hennies HC. Am J Hum Genet. 2010 Aug 13;87(2):274-81.

The hair collar sign - a possible indication of cranial dysraphism. Held I, Rose C, Hamm H, Fölster-Holst R. J Dtsch Dermatol Ges. 2011 Feb;9(2):136-8.

Propranolol in the therapy of infantile hemangioma--fascinating, but not with risk. Fölster-Holst R. J Dtsch Dermatol Ges. 2010 Mar;8(3):149-50.

Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, Fölster-Holst R, Proksch E, Schröder JM, Schwarz T, Gläser R. J Invest Dermatol. 2010 May;130(5):1355-64. Epub 2010 Jan 28.

Prednisolone vs. ciclosporin for severe adult eczema. An investigator-initiated double-blind placebo-controlled multicentre trial. Schmitt J, Schäkel K, Fölster-Holst R, Bauer A, Oertel R, Augustin M, Aberer W, Luger T, Meurer M. Br J Dermatol. 2010 Mar;162(3):661-8.

Allergen microarrays: a novel tool for high-resolution IgE profiling in adults with atopic dermatitis. Ott H, Fölster-Holst R, Merk HF, Baron JM. Eur J Dermatol. 2010 Jan-Feb;20(1):54-61. Epub 2009 Oct 2.

Eczematous skin lesions of a suckling. Panzer R, Fölster-Holst R. J Dtsch Dermatol Ges. 2009 Oct;7(10):913-4.

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Ott H, Sieber J, Brehler R, Fölster-Holst R, Kapp A, Klimek L, Pfaar O, Merk H. Allergy. 2009 Sep;64(9):1394-401.

Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis. Ott H, Wilke J, Baron JM, Höger PH, Fölster-Holst R. J Eur Acad Dermatol Venereol. 2010 Apr;24(4):395-402.

Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. Jensen JM, Pfeiffer S, Witt M, Bräutigam M, Neumann C, Weichenthal M, Schwarz T, Fölster-Holst R, Proksch E. J Allergy Clin Immunol. 2009 Sep;124(3 Suppl 2):R19-28.

Dyschromatosis ptychotropica: an unusual pigmentary disorder in a boy with epileptic encephalopathy and progressive atrophy of the central nervous system-a novel entity? Helbig I, Fölster-Holst R, Brasch J, Hausser I, van Baalen A, Muhle H, Alfke K, Caliebe A, Stephani U, Happle R. Eur J Pediatr. 2010 Apr;169(4):495-500